ISRG Intuitive Surgical, Inc.
Trend channel, buy level and 3-month target. Information only, not financial advice.
Above the channel · 12-month channel falling
Closed above resistance (US$359.92). The fitted trend may no longer apply.
- 12-month channel
- US$321.05 – US$359.25 · falling, −39% a year
- Price in channel
- 288% (0% = floor, 100% = ceiling)
- Ceiling overhead
- none — above both ceilings
- Turns bearish below
- US$321.57
What broke this trend
- The fall
- -46% from US$610.4022 Jan 2025 → 23 July 2026
- Whose problem it was
- This companyno peer group to compare against
- Does it resolve?
- Temporary falls like it have resolved on the record
- Regained so far
- 36%of what it lost
- What the record says
- 72% of 817 comparable falls came back, typically in 99 days measured across every stock we hold history for, its peer group being too small
Fell -46% (22 Jan 2025 → 23 July 2026); regained 36% so far; company-specific.
Reported at the time: A Closer Look at Intuitive Surgical's Options Market Dynamics — 17 Jan 2025
Price history, with the path projected 3 months forward
Updated 10:26 PM ET (13 h ago)
- Daily close
- Upper trend line (12 months)
- Lower trend line (12 months)
- The same lines over the last 12 months
- Dashed after today: projected 3 months
- Our buy
- Our target
Our target
No published call: the falling channel’s upper wall (359.35) leaves less than the 6% a call has to clear, and no target is set above a descending wall Levels below are for reference only.
Buy at or below
US$320.97
level as at 1 Nov 2026
Our target
US$359.15
by 2 Nov 2026
Projected move
11.9%
gross, before costs
Price is at or past our target.
10 settled calls · 7 reached target (70%) · average best move 11.1%. See the full record.
- Upper line touches
- 3
- Lower line touches
- 3
- Fit confidence
- 63%
- Fitted
- 1 Nov 2026
Company information
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- David J. Rosa
- Employees
- 17,021
- Country
- US
Scorecard
Our own scores from the fundamentals below (not Morningstar ratings).
- Valuation
- —
- Profitability
- —
- Financial health
- —
- Cash generation
- —
Key statistics
- Market cap
- US$150.74B
- Enterprise value
- —
- Beta
- 1.46
- Avg volume
- 2.77M
- Revenue per share
- —
- Dividend yield
- —
- 52-week range
- 328.57-603.88
- Exchange
- NASDAQ
Key ratios
- P/E (TTM)
- —
- PEG
- —
- Price / sales
- —
- Price / book
- —
- EV / EBITDA
- —
- Gross margin
- —
- Operating margin
- —
- Net margin
- —
- Current ratio
- —
- Quick ratio
- —
- Debt / equity
- —
- Interest cover
- —
Income statement
Balance sheet
Cash flow
Trend lines are fitted to past swing highs and lows and may not continue. Information only, not financial advice.